Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:09 PM
Ignite Modification Date:
2025-12-24 @ 12:09 PM
NCT ID:
NCT02453061
Eligibility Criteria:
Inclusion Criteria:
* Positive genetic test with CAG repeat length ≥39 in HTT gene
* At least 18 years of age
* Signature of informed consent
* Covered by social security
* UHDRS score between 5 and 40
* Ability to undergo MRI scanning
* BMI between 18 and 30
Exclusion Criteria:
* Hypersensitivity to triheptanoin or to one of its excipients
* Additional major comorbidities
* History of severe head injury
* Participation in another therapeutic trial (3 month exclusion period)
* For women of childbearing age, the absence of two forms of effective contraception (with the exception of those who are abstinent)
* Pregnancy or breastfeeding
* Inability to understand information about the protocol
* Persons deprived of their liberty by judicial or administrative decision
* Adult subject under legal protection or unable to consent
* Treatment with tetrabenazine
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02453061
Study Brief:
Protocol Section:
NCT02453061